A feeding trial was conducted to evaluate the effects of nucleotide (NT) supplementation in diet on immune responses and disease resistance of juvenile hybrid tilapia, Oreochromis niloticus × Oreochromis aureus. Nucleotide was added at 0, 120, 240, 360, 480 and 600 mg NT/kg to low fish meal (6%) and high soybean meal (56%) basal diet for a total of 6 experimental diets. Each diet was fed to triplicate groups of tilapia (initial body weight 0.15 ± 0.005 g) in a recirculated freshwater rearing system for 10 weeks. Head kidney leukocyte superoxide anion production ratio was higher (P < 0.05) in fish fed diets supplemented with ≥240 mg NT/kg than that in fish fed the NT unsupplemented control diet. Fish fed the diet supplemented with 240 mg NT/kg had higher plasma lysozyme activity than fish fed diets supplemented with ≤120 mg NT/kg. The stimulation index (SI) of head kidney leukocyte stimulated with ConA was higher in fish fed diets supplemented with ≥120 mg NT/kg than that in fish fed the control diet. The SI of leukocyte stimulated with PHA-P was higher in fish fed diets supplemented with ≥240 mg NT/kg than in fish fed diets supplemented with ≤120 mg NT/kg. After the feeding trial, 10 fish were randomly selected from each aquarium and were challenged with Streptococcus iniae for 7 days, higher survival (>80%) were observed in fish fed diets supplemented with NT than fish fed the NT unsupplemented control diet (56.7%). These results suggest that nucleotides supplemented at 120–240 mg NT/kg in diet enhances immune responses and survival of tilapia fed low fish meal and high soybean meal diet.
No takes yet. Share an insight, caveat, or question.
Shiau et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: